Autism Treatment Market: By Autism Type ; By Treatment Approach By Drug, By Region Forecast 2019-2030  

download arrow download arrow Download Free Sample
settings arrow settings arrow email us

Autism Treatment Market Size, Share, Growth, Trends, and Global Industry Analysis: By Autism Type (Autistic Disorder, Asperger Syndrome, Pervasive Developmental Disorder, Childhood Disintegrative Disorder); By Treatment Approach (Behavioural Approaches, Early Intervention, Medication, Dietary Approach) By Drug (Risperidone, Aripiprazole, Clozapine, Haloperidol, Sertraline, Methylphenidate, Venlafaxine, Fluoxetine, Others), By Region Forecast 2019-2030  

checked icon arrow_drop_down
checked icon Single User License $4400 $3520
checked icon Multiple User License $6600 $5280
checked icon Corporate User License $8900 $7120

Autism Treatment Market size was valued at US$ 29,123.2 million in 2023, growing at a CAGR of 6.2% from 2024 to 2030. The global market provides a detailed overview that can be segmented by autism type, by treatment approach, and by drug. By autism type, the global market has been segmented into Autistic Disorder, Asperger Syndrome, Pervasive Developmental Disorder, and Childhood Disintegrative Disorder. The Autistic Disorder segment is likely to be the largest and fastest-growing segment in terms of type in 2021 due to the high prevalence of this disease. Based on treatment approach, the market is segmented into Behavioural Approaches, Early Intervention, Medication, and Dietary Approaches. Among these, the Behavioural Approaches segment is expected to have the fastest-growing market during the forecast period. 

According to precision business insights. Based on the drug, the global market is segmented into Risperidone, Aripiprazole, Clozapine, Haloperidol, Sertraline, Methylphenidate, Venlafaxine, Fluoxetine, and Others. The Risperidone segment accounts for the largest share in 2021 and is expected to maintain the trend in the upcoming years. It is attributed to increased focus and decreased hyperactivity in the patient. Autism spectrum disorders, or pervasive developmental disorders (PDDs), are neurodevelopmental disorders which a subjective disability in a social association, debilitated correspondence, and stereotyped examples of conduct. The most well-known types of PDD are autistic issues, Asperger's issues, and unavoidable formative issues not generally indicated (PDD NOS). The increased prevalence of autism is anticipated to create demand for the market.

Autism Treatment Market Key Development

  • In Oct 2022, AXA Health launched neurodiversity services for group PMI In May 2022, Group launched mobile application for Autism therapy in Nigeria.

summary download arrow Download Free Sample

Global Autism Treatment Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

6.2%

Largest Market

Asia-Pacific

Fastest Growing Market

North-America

Autism Treatment Market Dynamics

Growing predominance of a mental imbalance and Pervasive Developmental Disorder (PDD) and rising mindfulness are anticipated to propel the market growth over the forecast years.

Global Autism Treatment Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2024-2030

Market Size in 2023

US$ 29,123.2 million

Market CAGR

6.2%

By Autism Type

  • Autistic Disorder
  • Asperger Syndrome
  • Pervasive Developmental Disorder
  • Childhood Disintegrative Disorder

By Based on Treatment

  • Behavioural Approaches
  • Early Intervention
  • Medication
  • Dietary Approach

By Drugs

  • Risperidone
  • Aripiprazole
  • Clozapine
  • Haloperidol
  • Sertraline
  • Methylphenidate
  • Venlafaxine
  • Fluoxetine
  • Others

Key Features of the Report

  • The autism treatment market report provides granular level information about the market size, regional market share, historic market (2019-2023) and forecast (2024-2030)
  • The report covers in-detail insights about the competitors overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario

Download Free Sample Report

I accept the Terms and Conditions,Disclaimers, GDPR Policy

Frequently Asked Questions

The global autism treatment market size was valued at US$ 29,123.2 million in 2023 and is projected to grow at a CAGR of 6.2% from 2024 to 2030.

The autism treatment market key players are: Pfizer, Inc. (U.S.) Sanofi (France) Boehringer Ingelheim (Germany) Novartis International AG (Switzerland) GlaxoSmithKline plc (U.K.) Bristol-Myers Squibb (U.S.) Teva Pharmaceutical Industries Ltd.(Israel) Aurobindo Pharma Limited (India) Eli Lilly and Company (U.S.) AbbVie Inc. (U.S.). Merck & Co., Inc. (U.S.)

The autism treatment market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1. Executive Summary
2. Global Autism Treatment Market Introduction 
2.1.Global Autism Treatment Market  - Taxonomy
2.2.Global Autism Treatment Market  - Definitions
2.2.1.Autism Type
2.2.2.Based on Treatment
2.2.3.Drugs
2.2.4.Region
3. Global Autism Treatment Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4. Global Autism Treatment Market Analysis, 2019 - 2023 and Forecast 2024 - 2030
4.1.  Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5. Global Autism Treatment Market  By Autism Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
5.1. Autistic Disorder
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Asperger Syndrome
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Pervasive Developmental Disorder
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Childhood Disintegrative Disorder
5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
6. Global Autism Treatment Market  By Based on Treatment, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
6.1. Behavioural Approaches
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Early Intervention
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Medication
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Dietary Approach
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
7. Global Autism Treatment Market  By Drugs, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
7.1. Risperidone
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Aripiprazole
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Clozapine
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Haloperidol
7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
7.5. Sertraline
7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.5.3. Market Opportunity Analysis 
7.6. Methylphenidate
7.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.6.3. Market Opportunity Analysis 
7.7. Venlafaxine
7.7.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.7.3. Market Opportunity Analysis 
7.8. Fluoxetine
7.8.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.8.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.8.3. Market Opportunity Analysis 
7.9. Others
7.9.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.9.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.9.3. Market Opportunity Analysis 
8. Global Autism Treatment Market  By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
8.1. North America
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Europe
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Asia Pacific (APAC)
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Middle East and Africa (MEA)
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
8.5. Latin America
8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.5.3. Market Opportunity Analysis 
9. North America Autism Treatment Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
9.1. Autism Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Autistic Disorder
9.1.2.Asperger Syndrome
9.1.3.Pervasive Developmental Disorder
9.1.4.Childhood Disintegrative Disorder
9.2.  Based on Treatment Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Behavioural Approaches
9.2.2.Early Intervention
9.2.3.Medication
9.2.4.Dietary Approach
9.3.  Drugs Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Risperidone
9.3.2.Aripiprazole
9.3.3.Clozapine
9.3.4.Haloperidol
9.3.5.Sertraline
9.3.6.Methylphenidate
9.3.7.Venlafaxine
9.3.8.Fluoxetine
9.3.9.Others
9.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.4.1.United States of America (USA)
9.4.2.Canada
10. Europe Autism Treatment Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
10.1. Autism Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Autistic Disorder
10.1.2.Asperger Syndrome
10.1.3.Pervasive Developmental Disorder
10.1.4.Childhood Disintegrative Disorder
10.2.  Based on Treatment Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Behavioural Approaches
10.2.2.Early Intervention
10.2.3.Medication
10.2.4.Dietary Approach
10.3.  Drugs Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Risperidone
10.3.2.Aripiprazole
10.3.3.Clozapine
10.3.4.Haloperidol
10.3.5.Sertraline
10.3.6.Methylphenidate
10.3.7.Venlafaxine
10.3.8.Fluoxetine
10.3.9.Others
10.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Germany
10.4.2.France
10.4.3.Italy
10.4.4.United Kingdom (UK)
10.4.5.Spain
10.4.6.Rest of EU
11. Asia Pacific (APAC) Autism Treatment Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
11.1. Autism Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Autistic Disorder
11.1.2.Asperger Syndrome
11.1.3.Pervasive Developmental Disorder
11.1.4.Childhood Disintegrative Disorder
11.2.  Based on Treatment Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Behavioural Approaches
11.2.2.Early Intervention
11.2.3.Medication
11.2.4.Dietary Approach
11.3.  Drugs Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Risperidone
11.3.2.Aripiprazole
11.3.3.Clozapine
11.3.4.Haloperidol
11.3.5.Sertraline
11.3.6.Methylphenidate
11.3.7.Venlafaxine
11.3.8.Fluoxetine
11.3.9.Others
11.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.China
11.4.2.India
11.4.3.Australia and New Zealand (ANZ)
11.4.4.Japan
11.4.5.Rest of APAC
12. Middle East and Africa (MEA) Autism Treatment Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
12.1. Autism Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Autistic Disorder
12.1.2.Asperger Syndrome
12.1.3.Pervasive Developmental Disorder
12.1.4.Childhood Disintegrative Disorder
12.2.  Based on Treatment Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Behavioural Approaches
12.2.2.Early Intervention
12.2.3.Medication
12.2.4.Dietary Approach
12.3.  Drugs Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Risperidone
12.3.2.Aripiprazole
12.3.3.Clozapine
12.3.4.Haloperidol
12.3.5.Sertraline
12.3.6.Methylphenidate
12.3.7.Venlafaxine
12.3.8.Fluoxetine
12.3.9.Others
12.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.GCC Countries
12.4.2.South Africa
12.4.3.Rest of MEA
13. Latin America Autism Treatment Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
13.1. Autism Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Autistic Disorder
13.1.2.Asperger Syndrome
13.1.3.Pervasive Developmental Disorder
13.1.4.Childhood Disintegrative Disorder
13.2.  Based on Treatment Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Behavioural Approaches
13.2.2.Early Intervention
13.2.3.Medication
13.2.4.Dietary Approach
13.3.  Drugs Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Risperidone
13.3.2.Aripiprazole
13.3.3.Clozapine
13.3.4.Haloperidol
13.3.5.Sertraline
13.3.6.Methylphenidate
13.3.7.Venlafaxine
13.3.8.Fluoxetine
13.3.9.Others
13.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Brazil
13.4.2.Mexico
13.4.3.Rest of LA
14. Competition Landscape
14.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
14.2.1.Pfizer, Inc. (U.S.)
14.2.2.Sanofi (France)
14.2.3.Boehringer Ingelheim (Germany)
14.2.4.Novartis International AG (Switzerland)
14.2.5.GlaxoSmithKline plc (U.K.)
14.2.6.Bristol-Myers Squibb (U.S.)
14.2.7.Teva Pharmaceutical Industries Ltd.(Israel)
14.2.8.Aurobindo Pharma Limited (India)
14.2.9.Eli Lilly and Company (U.S.)
14.2.10.AbbVie Inc. (U.S.).
14.2.11.Merck & Co., Inc. (U.S.)
15. Research Methodology 
16. Appendix and Abbreviations 

Key Market Players

  • Pfizer, Inc. (U.S.)
  • Sanofi (France)
  • Boehringer Ingelheim (Germany)
  • Novartis International AG (Switzerland)
  • GlaxoSmithKline plc (U.K.)
  • Bristol-Myers Squibb (U.S.)
  • Teva Pharmaceutical Industries Ltd.(Israel)
  • Aurobindo Pharma Limited (India)
  • Eli Lilly and Company (U.S.)
  • AbbVie Inc. (U.S.).
  • Merck & Co., Inc. (U.S.)

Related Industry Reports

Brain Health Supplements Market

U K Private Healthcare Market

Global Healthcare Analytics Market

Global Bone And Joint Health Supplements Market